Laryngomalacia is a rare voice disorder that affects the larynx, or voice box, of an individual. It is the most common cause of stridor, a high-pitched sound that occurs when an individual breathes in. The disorder is most commonly seen in infants, but can also affect adults. The exact cause of laryngomalacia is unknown, however, there are a few factors that can contribute to the development of the disorder. In this article, we will explore the causes and treatments of laryngomalacia, providing a guide to understanding this rare voice disorder.
Laryngomalacia is a congenital disorder that affects the larynx, or voice box, of an individual. It is the most common cause of stridor, a high-pitched sound that occurs when an individual breathes in. The disorder is most commonly seen in infants, but can also affect adults. The exact cause of laryngomalacia is unknown, however, there are a few factors that can contribute to the development of the disorder. The larynx is composed of two layers of tissue: the inner layer is the mucosa, and the outer layer is the cartilage. In individuals with laryngomalacia, the mucosa is soft and floppy, and the cartilage is weak. This causes the larynx to collapse during inhalation, resulting in the stridor sound.
The exact cause of laryngomalacia is unknown, however, there are a few factors that can contribute to the development of the disorder. These include: • Abnormal development of the larynx: This can be caused by a genetic mutation or an underlying medical condition. • Weak muscles in the larynx: This can be caused by a congenital defect or an underlying medical condition. • Abnormal positioning of the larynx: This can be caused by a birth defect or an underlying medical condition. • Abnormal airway anatomy: This can be caused by a birth defect or an underlying medical condition.
The most common symptom of laryngomalacia is stridor, a high-pitched sound that occurs when an individual breathes in. Other symptoms may include: • Coughing • Wheezing • Difficulty breathing • Gagging • Choking • Cyanosis (blue skin) • Feeding difficulties • Poor weight gain
The diagnosis of laryngomalacia is typically made based on the individual’s medical history, physical examination, and imaging studies. Imaging studies may include x-rays, CT scans, and MRI scans. These imaging studies may help to identify any underlying medical conditions that may be causing or contributing to the laryngomalacia.
The treatment of laryngomalacia is typically aimed at improving the individual’s breathing and reducing the stridor. Treatment may include: • Medications: Medications may be prescribed to help reduce inflammation and swelling in the larynx. • Surgery: Surgery may be recommended to remove any tissue that is blocking the airway or to strengthen the larynx. • Speech therapy: Speech therapy may be recommended to help the individual learn how to use their voice more effectively. • Oxygen therapy: Oxygen therapy may be recommended to help the individual breathe more easily.
Laryngomalacia is a rare voice disorder that affects the larynx, or voice box, of an individual. It is the most common cause of stridor, a high-pitched sound that occurs when an individual breathes in. The exact cause of laryngomalacia is unknown, however, there are a few factors that can contribute to the development of the disorder. Treatment of laryngomalacia is typically aimed at improving the individual’s breathing and reducing the stridor. Treatment may include medications, surgery, speech therapy, and oxygen therapy. With proper diagnosis and treatment, individuals with laryngomalacia can lead a normal life.
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
3.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
4.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
5.
A promising medication could slow brain tumors in children.
1.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
2.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
3.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Generative AI for Adaptive Oncology Trial Design
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation